Categories AlphaGraphs, Earnings, Health Care
Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in the same period a year ago.
GAAP net income rose 6% year-over-year to $819 million, or $3.15 per share. Adjusted EPS increased 25% to $3.76.
For full-year 2023, CF product revenues are expected to be $9.55-9.70 billion.
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Philip Morris International (PM) Q1 2025 Earnings: Key financials and quarterly highlights
Philip Morris International Inc. (NYSE: PM) reported its first quarter 2025 earnings results today. Net revenues increased 5.8% year-over-year to $9.3 billion. Organic revenue growth was 10.2%. Net earnings attributable
General Dynamics (GD) Q1 2025 profit jumps; revenue up 14%
Aerospace company General Dynamics (NYSE: GD) reported a sharp increase in earnings for the first quarter of 2025, reflecting a double-digit growth in revenues. First-quarter revenue increased 14% year-over-year to
Infographic: How Boeing (BA) performed in Q1 2025
The Boeing Company (NYSE: BA) reported its first quarter 2025 earnings results today. Revenues increased 18% year-over-year to $19.5 billion. Net loss attributable to Boeing shareholders amounted to $37 million,
